This is a request for quotes for a new five-year Blanket Purchase Agreement to provide non-invasive prostate cancer testing for VISN 19 medical facilities. The contractor must supply a urine-based molecular liquid biopsy test that produces a risk score for aggressive prostate cancer, with test kits shipped directly to patients' homes or to specified VISN 19 facility laboratories in Colorado, Montana, Oklahoma, and Utah, including prepaid return labels. The government anticipates awarding a firm-fixed-price contract on an all-or-nothing basis. Quotes will be evaluated using a best-value comparative analysis based on technical capability, past performance, and price. Offerors must submit volumes covering technical capability, past performance references, pricing, and BPA terms.